SYK
Stryker Corporation
Is SYK Halal?
Medical devices — orthopedic implants and surgical equipment preserve life.
What You Should Know
Stryker makes orthopedic implants, surgical instruments, and medical devices. Life-preserving medical technology is generally permissible. Its March 31, 2026 Form 10-Q reports $46,291 million of assets, $15,234 million of debt including operating leases, $2,878 million of cash, $87 million of debt securities, $3,571 million of receivables and $6,020 million of quarterly revenue. Debt/assets is 32.91%, liquidity/assets is 6.41%, receivables-plus-cash/assets is 13.93% and disclosed interest income is 0.56%; examined financial ratios pass, while activity allocation remains qualitative.
⚠️ Concerns
- •Debt/assets is close to the examined 33% limits
- •Acquisition-related leverage
- •Disclosed interest income
- •Medical-device customer and end-use mix requires qualitative review
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
15,234 / 46,291
2,965 / 46,291
6,449 / 46,291
34 / 6,020
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 32.91%, liquidity/assets is 6.41%, receivables-plus-cash/assets is 13.93% and disclosed interest income is 0.56%; examined financial ratios pass, but the activity numerator remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt, liquidity and receivables-plus-cash are below the examined total-assets limits; activity allocation remains incomplete. This is not an index-membership claim.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets and identifiable conventional cash and securities are below the examined Malaysia limits; activity allocation remains incomplete.
- Financial
- Not calculated
- Overall
- Incomplete
A properly licensed and reproducible historical market-cap series is not stored.
Business-activity disclosure
Stryker develops and sells orthopedic implants, surgical instruments, neurovascular products and other medical technology. The life-preserving medical-device business is generally permissible, while customer, procedure and end-use allocation requires qualitative review.
Limitation: The filing does not provide a universal prohibited-activity numerator across customers, procedures and end uses.
Purification
Stryker discloses $34 million of interest income but does not provide a scholar-approved purification percentage or complete prohibited-activity numerator.
Inputs, assumptions and primary sources
- Amounts are USD millions from Stryker's March 31, 2026 Form 10-Q.
- Interest-bearing debt is $14,723 million of current and noncurrent debt plus $511 million of operating-lease liabilities; leases are included conservatively.
- Cash and cash equivalents are $2,878 million, current available-for-sale debt securities are $87 million and accounts receivable are $3,571 million.
- Quarterly revenue is $6,020 million and separately disclosed interest income is $34 million, or 0.56% of quarterly revenue.
- Medical devices are generally permissible, but the filing does not provide a universal prohibited-activity numerator across customers, procedures and end uses.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →